Immune health Medicines Approved in the EU (EMA)

• 23medicines authorised in the EU (authorised now)

Each number has its full source under its own list below.

• 15Apr2026

  Enflonsia

  Active substance: clesrovimab

  EMEA/H/C/006497
• 22Dec2025

  Wayrilz

  Active substance: rilzabrutinib

  EMEA/H/C/006425
• 2May2025

  Deqsiga

  Active substance: human normal immunoglobulin

  EMEA/H/C/006423
• 28Mar2025

  Eltrombopag Accord

  Active substance: eltrombopag olamine

  EMEA/H/C/006459
• 20Jan2025

  Kavigale

  Active substance: sipavibart

  EMEA/H/C/006291
• 12Dec2024

  Eltrombopag Viatris

  Active substance: eltrombopag olamine

  EMEA/H/C/006417
• 31Oct2022

  Beyfortus

  Active substance: nirsevimab

  EMEA/H/C/005304
• 13Dec2021

  Aspaveli

  Active substance: pegcetacoplan

  EMEA/H/C/005553
• 21Jun2021

  Jayempi

  Active substance: azathioprine

  EMEA/H/C/005055
• 9Jan2020

  Tavlesse

  Active substance: Fostamatinib disodium

  EMEA/H/C/005012
• 20Jun2019

  Doptelet

  Active substance: avatrombopag maleate

  EMEA/H/C/004722
• 16May2013

  HyQvia

  Active substance: human normal immunoglobulin

  EMEA/H/C/002491
• 14Apr2011

  Hizentra

  Active substance: human normal immunoglobulin (SCIg)

  EMEA/H/C/002127
• 11Mar2010

  Revolade

  Active substance: eltrombopag

  EMEA/H/C/001110
• 30Nov2009

  Zutectra

  Active substance: human hepatitis B immunoglobulin

  EMEA/H/C/001089

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

• Skin and hair
• Bones and joints
• Allergies